共 536 条
[1]
Morgan LL(2015)The epidemiology of glioma in adults: a state of the science review Neuro Oncol 17 623-624
[2]
Miller KD(2021)Brain and other central nervous system Tumor statistics, 2021 CA Cancer J Clin 71 381-406
[3]
Ostrom QT(2010)Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 1963-1972
[4]
Kruchko C(2012)Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria Neuro Oncol 14 667-673
[5]
Patil N(2010)Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas Lancet Neurol 9 906-920
[6]
Tihan T(2016)Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas Neuro Oncol 18 1199-1208
[7]
Cioffi G(2014)Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients Neuro Oncol 16 603-609
[8]
Fuchs HE(2021)Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group Neuro Oncol 23 881-893
[9]
Waite KA(2020)Diagnostic Accuracy of PET Tracers for the differentiation of Tumor Progression from Treatment-related changes in high-Grade Glioma: a systematic review and metaanalysis J Nucl Med 61 498-504
[10]
Jemal A(2020)(18)F-FET PET imaging in differentiating glioma progression from treatment-related changes: a single-center experience J Nucl Med 61 505-511